Dr. Robert A. Nagourney, MDOct 13, 20222 minFibrolamellar Cancer Foundation Symposium September 29, 2022
Dr. Robert A. Nagourney, MDSep 20, 20222 minDo The Mutations That Drive Cancer Actually Affect Immunity?
Dr. Robert A. Nagourney, MDAug 29, 20222 minIN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOU
Dr. Robert A. Nagourney, MDAug 15, 20223 minSTAGE IV PANCREATIC CANCER: A GOOD OPTION AFTER FOLFIRINOX?
Dr. Robert A. Nagourney, MDAug 10, 20223 minStage 4 Triple-Negative Breast Cancer: The Right Treatment May Be At Hand.
Dr. Robert A. Nagourney, MDAug 8, 20222 minChemosensitivity Testing Must Evolve at All Medical Providers
Dr. Robert A. Nagourney, MDJul 13, 20222 minWHEN THERE’S NO RIGHT ANSWER THERE ARE MANY WRONG ANSWERS
Dr. Robert A. Nagourney, MDApr 24, 20222 minJUST BECAUSE A DRUG WORKS DOESN’T MEAN THEY’LL PAY FOR IT